Fractyl Health to Present at Major Investor Conferences
Fractyl Health, Inc. (Nasdaq: GUTS), a trailblazer in the field of metabolic therapeutics, is committed to tackling the underlying issues of obesity and Type 2 Diabetes (T2D). The company's Co-founder and CEO, Harith Rajagopalan, M.D., Ph.D., is set to deliver significant presentations at two key investor conferences, reinforcing Fractyl's mission to create effective treatments.
Details of Upcoming Conferences
Fractyl Health will highlight its groundbreaking strategies through presentations at the following events:
Morgan Stanley Global Healthcare Conference
This event will feature a fireside chat format, providing an opportunity for engaging discussions about the future of metabolic therapeutics.
Date: September 6, 2024
Time: 10:45 AM ET
H.C. Wainwright 26th Annual Global Investment Conference
Following the first conference, Fractyl's leadership will present in a formal setting, where they will discuss recent advancements and future initiatives.
Date: September 9, 2024
Time: 2:00 PM ET
How to Access Conference Replays
Those interested can view both presentations through webcast replays, which will be available on the Events page within the Investor section of Fractyl Health’s website.
About Fractyl Health
Fractyl Health is at the forefront of metabolic therapeutics, working to improve the treatment landscape for metabolic diseases such as obesity and T2D. Despite significant advancements in recent decades, these conditions continue to be widespread and pose serious health challenges. Fractyl Health seeks to shift the focus from merely managing symptoms to developing lasting, disease-modifying therapies that address the root causes.
Located in Burlington, MA, Fractyl Health is dedicated to creating innovative solutions that assist those affected by metabolic diseases and enhance overall health outcomes.
Contacts
Corporate Contact
Lisa Davidson, Chief Financial Officer
Email: ir@fractyl.com, Phone: 781.902.8800
Media Contact
Jessica Cotrone, Corporate Communications
Email: jcotrone@fractyl.com, Phone: 978.760.5622
Investor Contact
Stephen Jasper, Gilmartin Group
Email: stephen@gilmartinir.com, Phone: 619.949.3681
Frequently Asked Questions
What is Fractyl Health known for?
Fractyl Health is recognized as a leader in metabolic therapeutics, focusing on innovative treatments for obesity and Type 2 Diabetes.
When is the next investor conference for Fractyl Health?
The next investor conference is the Morgan Stanley Global Healthcare Conference, scheduled for September 6, 2024.
How can I watch the presentations from the investor conferences?
Webcast replays of the conferences will be accessible on the Events page of Fractyl Health’s Investor section after the live sessions conclude.
Who is the CEO of Fractyl Health?
Harith Rajagopalan, M.D., Ph.D., serves as the Co-founder and Chief Executive Officer of Fractyl Health.
What is the goal of Fractyl Health?
Fractyl Health aims to transform the treatment of metabolic diseases by focusing on durable therapies that target root causes rather than just managing symptoms.
